151 related articles for article (PubMed ID: 37684258)
1. Discrepancies in indel software resolution with somatic CRISPR/Cas9 tumorigenesis models.
Brockman QR; Scherer A; McGivney GR; Gutierrez WR; Rytlewski J; Sheehan A; Warrier A; Laverty EA; Roughton G; Carnevale NC; Knepper-Adrian V; Dodd RD
Sci Rep; 2023 Sep; 13(1):14798. PubMed ID: 37684258
[TBL] [Abstract][Full Text] [Related]
2. Distinct Tumor Microenvironments Are a Defining Feature of Strain-Specific CRISPR/Cas9-Induced MPNSTs.
Scherer A; Stephens VR; McGivney GR; Gutierrez WR; Laverty EA; Knepper-Adrian V; Dodd RD
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32456131
[TBL] [Abstract][Full Text] [Related]
3. Fast and Quantitative Identification of Ex Vivo Precise Genome Targeting-Induced Indel Events by IDAA.
König S; Yang Z; Wandall HH; Mussolino C; Bennett EP
Methods Mol Biol; 2019; 1961():45-66. PubMed ID: 30912039
[TBL] [Abstract][Full Text] [Related]
4. Development of methods for effective identification of CRISPR/Cas9-induced indels in rice.
Biswas S; Li R; Yuan Z; Zhang D; Zhao X; Shi J
Plant Cell Rep; 2019 Apr; 38(4):503-510. PubMed ID: 30783736
[TBL] [Abstract][Full Text] [Related]
5. Low incidence of SNVs and indels in trio genomes of Cas9-mediated multiplex edited sheep.
Wang X; Liu J; Niu Y; Li Y; Zhou S; Li C; Ma B; Kou Q; Petersen B; Sonstegard T; Huang X; Jiang Y; Chen Y
BMC Genomics; 2018 May; 19(1):397. PubMed ID: 29801435
[TBL] [Abstract][Full Text] [Related]
6. The novel insight into the outcomes of CRISPR/Cas9 editing intra- and inter-species.
Chang J; Chen X; Zhang T; Wang R; Wang A; Lan X; Zhou Y; Ma S; Xia Q
Int J Biol Macromol; 2020 Nov; 163():711-717. PubMed ID: 32652159
[TBL] [Abstract][Full Text] [Related]
7. Whole-Genome Sequencing Reveals Rare Off-Target Mutations in
Li Z; Lan J; Shi X; Lu T; Hu X; Liu X; Chen Y; He Z
CRISPR J; 2024 Feb; 7(1):29-40. PubMed ID: 38353621
[TBL] [Abstract][Full Text] [Related]
8. INDEL detection, the 'Achilles heel' of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels.
Bennett EP; Petersen BL; Johansen IE; Niu Y; Yang Z; Chamberlain CA; Met Ö; Wandall HH; Frödin M
Nucleic Acids Res; 2020 Dec; 48(21):11958-11981. PubMed ID: 33170255
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.
Sugano SS; Nishihama R
Methods Mol Biol; 2018; 1830():109-126. PubMed ID: 30043367
[TBL] [Abstract][Full Text] [Related]
10. Genome editing with CRISPR/Cas9 in Pinus radiata (D. Don).
Poovaiah C; Phillips L; Geddes B; Reeves C; Sorieul M; Thorlby G
BMC Plant Biol; 2021 Aug; 21(1):363. PubMed ID: 34376154
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide Analysis of Off-Target CRISPR/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones.
Smith RH; Chen YC; Seifuddin F; Hupalo D; Alba C; Reger R; Tian X; Araki D; Dalgard CL; Childs RW; Pirooznia M; Larochelle A
Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33322084
[TBL] [Abstract][Full Text] [Related]
12. Genotyping MUltiplexed-Sequencing of CRISPR-Localized Editing (GMUSCLE): An Experimental and Computational Approach for Analyzing CRISPR-Edited Cells.
Zhang P; Abel L; Casanova JL; Yang R
CRISPR J; 2023 Oct; 6(5):462-472. PubMed ID: 37824834
[TBL] [Abstract][Full Text] [Related]
13. A simple and practical workflow for genotyping of CRISPR-Cas9-based knockout phenotypes using multiplexed amplicon sequencing.
Iida M; Suzuki M; Sakane Y; Nishide H; Uchiyama I; Yamamoto T; Suzuki KT; Fujii S
Genes Cells; 2020 Jul; 25(7):498-509. PubMed ID: 32323394
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-GRANT: a cross-platform graphical analysis tool for high-throughput CRISPR-based genome editing evaluation.
Fu H; Shan C; Kang F; Yu L; Li Z; Yin Y
BMC Bioinformatics; 2023 May; 24(1):219. PubMed ID: 37254060
[TBL] [Abstract][Full Text] [Related]
15. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.
Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K
Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759
[TBL] [Abstract][Full Text] [Related]
16. Plasmid-based CRISPR-Cas9 system efficacy for introducing targeted mutations in CD81 gene of MDA-MB-231 cell line.
Arbabi Zaboli K; Rahimi H; Thekkiniath J; Taromchi AH; Kaboli S
Folia Histochem Cytobiol; 2022; 60(1):13-23. PubMed ID: 35157300
[TBL] [Abstract][Full Text] [Related]
17. indCAPS: A tool for designing screening primers for CRISPR/Cas9 mutagenesis events.
Hodgens C; Nimchuk ZL; Kieber JJ
PLoS One; 2017; 12(11):e0188406. PubMed ID: 29141013
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
19. Rapid and efficient generation of antigen-specific isogenic T cells from cryopreserved blood samples.
Eerkens AL; Vledder A; van Rooij N; Foijer F; Nijman HW; de Bruyn M
Immunol Cell Biol; 2022 Apr; 100(4):285-295. PubMed ID: 35194830
[TBL] [Abstract][Full Text] [Related]
20. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
